Genetic Analysis operates in the medical technology sector. The company conducts research and development in the field of diagnostics, with the greatest focus on the human microbiome. The technology is based on the company's research platform and the IVD products are used, for example, for testing and analysis of bacteria and viruses. The largest operations are found in the Nordic market and the products are mainly resold to laboratories. The company is headquartered in Oslo, Norway.

Quotes for Genetic Analysis AS

Right Now

+/-
0.06
%
7,06%
Latest
0.91
High
0.91
Low
0.79
Volume
91 659
Turnover (NOK)
75 419
Market Value (MNOK)
44,4
Time (Latest trade)

Board

CEO

  • Ronny Hermansen

Chairperson of the Board

  • Jethro Holter

Board

  • Camilla Huse Bondesson
  • Marie Buchmann
  • Richard Kurtz
  • Rune Sørum
  • Thorvald Steen

Largest Owners

Name Capital % Votes % Date
Bio-Rad Luxembourg S.À.R.L. 22,49 22,49 2024-12-31
Avanza Bank AB 10,32 10,32 2024-12-31
Muen Invest AS 6,65 6,65 2024-12-31
Nordnet Bank AB 4,98 4,98 2024-12-31
Lucellum AS 4,86 4,86 2024-12-31
Ochrino AS 4,16 4,16 2024-12-31
S. Munkhaugen AS 3,54 3,54 2024-12-31
Molver AS 2,93 2,93 2024-12-31
Biohit Oyj 2,88 2,88 2024-12-31
Leif Jørgen Moger 2,67 2,67 2024-12-31

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2025-08-27 Delårsrapport 2025-Q2

  • 2025-11-27 Delårsrapport 2025-Q3

  • 2026-02-25 Bokslutskommuniké 2025